Type 2 Diabetes

>

Latest News

GLP-1 RA Linked to Lower Risk of Cirrhosis Development in Patients with MASLD
GLP-1 RA Linked to Lower Risk of Cirrhosis Development in Patients with MASLD

September 16th 2024

A new study found glucagon-like peptide 1 receptor agonist use was associated with a lower risk of cirrhosis complications for patients with MASLD who did not have cirrhosis.

HCPLive Endocrinology Month In Review August 2024
Endocrinology Month in Review: August 2024

September 10th 2024

Brendon Neuen, MBBS, PhD | Credit: X.com
Brendon Neuen, MBBS, PhD: Expanding Evidence of Combination Therapy with GLP-1 RAs and SGLT2 Inhibitors

September 1st 2024

Brian Callaghan, MD, MS | Credit: Michigan Medicine
Study Finds Diabetes Complications and Mental Health Disorders Are a 2-Way Street

August 27th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Clears Omnipod 5 AID System for Type 2 Diabetes

August 26th 2024

<1
...
129130131132133
© 2024 MJH Life Sciences

All rights reserved.